Projects per year
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Kidney
Medicine & Life Sciences
Acute Kidney Injury
Medicine & Life Sciences
Diabetic Nephropathies
Medicine & Life Sciences
Renal Dialysis
Medicine & Life Sciences
Chronic Renal Insufficiency
Medicine & Life Sciences
Inflammation
Medicine & Life Sciences
Wounds and Injuries
Medicine & Life Sciences
Kidney Transplantation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 2013 2019
Research Output 1993 2018
A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats
Dorotea, D., Kwon, G., Lee, J. H., Saunders, E., Bae, Y. S., Moon, S. H., Lee, S. J., Cha, D-R. & Ha, H., 2018 Sep 1, In : Pharmacology. 102, 3-4, p. 180-189 10 p.Research output: Contribution to journal › Article
NADPH Oxidase
Diabetic Nephropathies
Kidney
Wounds and Injuries
Losartan
Association of serum mineral parameters with mortality in hemodialysis patients: Data from the korean end-stage renal disease registry
Kim, Y., Yoo, K. D., Kim, H. J., Koh, J., Yu, Y., Kwon, Y-J., Kim, G. H., Yoo, T. H., Lee, J., Jin, D. C., Choi, B. S., Kim, Y. H. & Oh, K. H., 2018 Sep 1, In : Kidney Research and Clinical Practice. 37, 3, p. 266-276 11 p.Research output: Contribution to journal › Article
Chronic Kidney Failure
Minerals
Registries
Renal Dialysis
Mortality
Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study
Han, S. Y., Yoon, S. A., Han, B. G., Kim, S. G., Jo, Y. I., Jeong, K. H., Oh, K. H., Park, H. C., Park, S. H., Kang, S. W., Na, K. R., Kang, S. W., Kim, N. H., Jang, Y., Kim, B., Shin, S. & Cha, D-R., 2018 Feb 1, In : Diabetes, Obesity and Metabolism. 20, 2, p. 292-300 9 p.Research output: Contribution to journal › Article
Type 2 Diabetes Mellitus
Kidney
Safety
Glomerular Filtration Rate
Placebos